{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:18:11Z","timestamp":1791897491041,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00103-019-03068-9","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T16:54:00Z","timestamp":1575305640000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Pr\u00e4valenz und Inzidenz des dokumentierten Diabetes mellitus \u2013 Referenzauswertung f\u00fcr die Diabetes-Surveillance auf Basis von Daten aller gesetzlich Krankenversicherten","Prevalence and incidence of documented diabetes based on health claims data\u2014reference analysis for diabetes surveillance in Germany"],"prefix":"10.1007","volume":"63","author":[{"given":"Christian","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Reitzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Dre\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ziese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Heidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"3068_CR1","doi-asserted-by":"publisher","first-page":"e000135","DOI":"10.1136\/bmjdrc-2015-000135","volume":"3","author":"Y Du","year":"2015","unstructured":"Du\u00a0Y, Heidemann\u00a0C, Schaffrath\u00a0RA et\u00a0al (2015) Changes in diabetes care indicators: findings from German National Health Interview and Examination Surveys 1997\u20131999 and 2008\u20132011. BMJ Open Diabetes Res Care 3:e135","journal-title":"BMJ Open Diabetes Res Care"},{"key":"3068_CR2","doi-asserted-by":"publisher","first-page":"e000451","DOI":"10.1136\/bmjdrc-2017-000451","volume":"5","author":"S R\u00f6ckl","year":"2017","unstructured":"R\u00f6ckl\u00a0S, Brinks\u00a0R, Baumert\u00a0J et al (2017) All-cause mortality in adults with and without type 2 diabetes: findings from the national health monitoring in Germany. BMJ Open Diabetes Res Care 5:e451","journal-title":"BMJ Open Diabetes Res Care"},{"key":"3068_CR3","first-page":"105","volume":"2","author":"C Heidemann","year":"2017","unstructured":"Heidemann\u00a0C, Scheidt-Nave\u00a0C (2017) Pr\u00e4valenz, Inzidenz und Mortalit\u00e4t von Diabetes mellitus bei Erwachsenen in Deutschland \u2013 Bestandsaufnahme zur Diabetes-Surveillance. J\u00a0Health Monit 2:105\u2013129","journal-title":"J Health Monit"},{"key":"3068_CR4","first-page":"83","volume":"2","author":"L Gabrys","year":"2017","unstructured":"Gabrys\u00a0L, Schmidt\u00a0C, Heidemann\u00a0C et al (2017) Diabetes-Surveillance in Deutschland \u2013 Hintergrund, Konzept, Ausblick. J\u00a0Health Monit 2:83\u201395","journal-title":"J Health Monit"},{"key":"3068_CR5","first-page":"3","volume":"3","author":"L Gabrys","year":"2018","unstructured":"Gabrys\u00a0L, Schmidt\u00a0C, Heidemann\u00a0C et al (2018) Diabetes-Surveillance in Deutschland \u2013 Auswahl und Definition von Indikatoren. J\u00a0Health Monit 3:3\u201322","journal-title":"J Health Monit"},{"key":"3068_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s11428-018-0419-7","volume":"15","author":"C Schmidt","year":"2019","unstructured":"Schmidt\u00a0C, Du\u00a0Y, Baumert\u00a0J et al (2019) Diabetes im Blick \u2013 Nationale Diabetes-Surveillance. Diabetologe 15:120\u2013127","journal-title":"Diabetologe"},{"key":"3068_CR7","first-page":"23","volume":"3","author":"R Paprott","year":"2018","unstructured":"Paprott\u00a0R, Heidemann\u00a0C, St\u00fchmann\u00a0LM et\u00a0al (2018) Erste Ergebnisse der Studie \u201eKrankheitswissen und Informationsbedarfe \u2013 Diabetes mellitus (2017)\u201c. J\u00a0Health Monit 3:23\u201362","journal-title":"J Health Monit"},{"key":"3068_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00103-017-2552-7","volume":"60","author":"C Schmidt","year":"2017","unstructured":"Schmidt\u00a0C, B\u00e4tzing-Feigenbaum\u00a0J, Bestmann\u00a0A et al (2017) Integration von Sekund\u00e4rdaten in die Nationale Diabetes-Surveillance. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 60:656\u2013661","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3068_CR9","volume-title":"Routinedaten im Gesundheitswesen: Handbuch Sekund\u00e4rdatenanalyse: Grundlagen, Methoden und Perspektiven","author":"H Gothe","year":"2014","unstructured":"Gothe\u00a0H, Ihle\u00a0P, Matusiewicz\u00a0D, Swart\u00a0E (2014) Routinedaten im Gesundheitswesen: Handbuch Sekund\u00e4rdatenanalyse: Grundlagen, Methoden und Perspektiven. Huber, Bern"},{"key":"3068_CR10","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/dme.12747","volume":"32","author":"N M\u00fcller","year":"2015","unstructured":"M\u00fcller\u00a0N, Heller\u00a0T, Freitag\u00a0MH et\u00a0al (2015) Healthcare utilization of people with Type 2 diabetes in Germany: an analysis based on health insurance data. Diabet Med 32:951\u2013957","journal-title":"Diabet Med"},{"key":"3068_CR11","first-page":"177","volume":"113","author":"T Tamayo","year":"2016","unstructured":"Tamayo\u00a0T, Brinks\u00a0R, Hoyer\u00a0A, Ku\u00df\u00a0O, Rathmann\u00a0W (2016) The prevalence and incidence of diabetes in Germany: an analysis of statutory health insurance data on 65\u202fMio. individuals from the years 2009 and 2010. Dtsch Arztebl Int 113:177","journal-title":"Dtsch Arztebl Int"},{"key":"3068_CR12","unstructured":"Goffrier B, Schulz M, B\u00e4tzing-Feigenbaum J (2017) Administrative Pr\u00e4valenzen und Inzidenzen des Diabetes mellitus von 2009 bis 2015. Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in Deutschland (Zi). Versorgungsatlas-Bericht Nr.\u00a017\/03.Berlin 2017. http:\/\/www.versorgungsatlas.de\/themen\/alle-analysen-nach-datum-sortiert\/?tab=6&uid=79. Zugegriffen: 7. Mai 2019"},{"key":"3068_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11943-019-00241-z","volume":"13","author":"J Breitkreuz","year":"2019","unstructured":"Breitkreuz\u00a0J, Br\u00fcckner\u00a0G, Burgard\u00a0JP et al (2019) Sch\u00e4tzung kleinr\u00e4umiger Krankheitsh\u00e4ufigkeiten f\u00fcr die deutsche Bev\u00f6lkerung anhand von Routinedaten am Beispiel von Typ-2-Diabetes. AStA Wirtsch Sozialstat Arch 13:35\u201372","journal-title":"AStA Wirtsch Sozialstat Arch"},{"key":"3068_CR14","unstructured":"Deutsches Institut f\u00fcr Medizinische Dokumentation und Information Basisinformation: Informationssystem Versorgungsdaten. https:\/\/www.dimdi.de\/static\/.downloads\/deutsch\/basisinfo-versorgungsdaten.pdf. Zugegriffen: 7. Mai 2019"},{"issue":"2","key":"3068_CR15","first-page":"54","volume":"4","author":"C Schmidt","year":"2019","unstructured":"Schmidt\u00a0C, Heidemann\u00a0C, Rommel\u00a0A et al (2019) Sekund\u00e4rdaten in der Diabetes-Surveillance \u2013 Kooperationsprojekte und Referenzdefinition zur dokumentierten Diabetespr\u00e4valenz. J\u00a0Health Monit 4(2):54\u201369","journal-title":"J Health Monit"},{"key":"3068_CR16","unstructured":"Deutsches Institut f\u00fcr Medizinische Dokumentation und Information Informationssystem Versorgungsdaten. https:\/\/www.dimdi.de\/dynamic\/de\/weitere-fachdienste\/versorgungsdaten. Zugegriffen: 7. Mai 2019"},{"key":"3068_CR17","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1055\/s-0036-1586672","volume":"78","author":"E Swart","year":"2016","unstructured":"Swart\u00a0E, Bitzer\u00a0EM, Gothe\u00a0H et\u00a0al (2016) Standardisierte Berichtsroutine f\u00fcr Sekund\u00e4rdaten Analysen (STROSA) \u2013 ein konsentierter Berichtsstandard f\u00fcr Deutschland, Version 2. Gesundheitswesen 78:e145\u2013e160","journal-title":"Gesundheitswesen"},{"key":"3068_CR18","unstructured":"Dr\u00f6sler S, Garbe E, Hasford J, Schubert I (2017) Sondergutachten zu den Wirkungen des morbidit\u00e4tsorientierten Risikostrukturausgleichs. https:\/\/www.bundesversicherungsamt.de\/fileadmin\/redaktion\/Risikostrukturausgleich\/Sondergutachten_Wirkung_RSA_2017.pdf. Zugegriffen: 3. Juni 2019"},{"issue":"1","key":"3068_CR19","first-page":"48","volume":"2","author":"C Heidemann","year":"2017","unstructured":"Heidemann\u00a0C, Kuhnert\u00a0R, Born\u00a0S, Scheidt-Nave\u00a0C (2017) 12-Monats-Pr\u00e4valenz des bekannten Diabetes mellitus in Deutschland. J\u00a0Health Monit 2(1):48\u201356","journal-title":"J Health Monit"},{"key":"3068_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00103-016-2493-6","volume":"60","author":"C Diederichs","year":"2017","unstructured":"Diederichs\u00a0C, Neuhauser\u00a0H, Kroll\u00a0L et\u00a0al (2017) Regionale Unterschiede in der Pr\u00e4valenz von kardiovaskul\u00e4ren Risikofaktoren bei M\u00e4nnern und Frauen in Deutschland. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 60:151\u2013162","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3068_CR21","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/dme.13008","volume":"33","author":"C Heidemann","year":"2016","unstructured":"Heidemann\u00a0C, Du\u00a0Y, Paprott\u00a0R, Haftenberger\u00a0M, Rathmann\u00a0W, Scheidt-Nave\u00a0C (2016) Temporal changes in the prevalence of diagnosed diabetes, undiagnosed diabetes and prediabetes: findings from the German Health Interview and Examination Surveys in 1997\u20131999 and 2008\u20132011. Diabet Med 33:1406\u20131414","journal-title":"Diabet Med"},{"key":"3068_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00103-012-1662-5","volume":"56","author":"C Heidemann","year":"2013","unstructured":"Heidemann\u00a0C, Du\u00a0Y, Schubert\u00a0I, Rathmann\u00a0W, Scheidt-Nave\u00a0C (2013) Prevalence and temporal trend of known diabetes mellitus: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56:668\u2013677","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3068_CR23","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","volume":"373","author":"M Tancredi","year":"2015","unstructured":"Tancredi\u00a0M, Rosengren\u00a0A, Svensson\u00a0A\u2011M et al (2015) Excess mortality among persons with Type 2 diabetes. N\u00a0Eng J Med 373:1720\u20131732","journal-title":"N Eng J Med"},{"key":"3068_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1475-6773.2011.01325.x","volume":"47","author":"S Abbas","year":"2012","unstructured":"Abbas\u00a0S, Ihle\u00a0P, K\u00f6ster\u00a0I, Schubert\u00a0I (2012) Estimation of disease incidence in claims data dependent on the length of follow-up: a methodological approach. Health Serv Res 47:746\u2013755","journal-title":"Health Serv Res"},{"key":"3068_CR25","unstructured":"Epping J, Tetzlaff K, Stuenrauch S, Geyer S (2019) Beeinflusst die Vorbeobachtungszeit die Inzidenzsch\u00e4tzung und Zeittrends bei Herzinfarkt, Schlaganfall und Lungenkrebs? In: Abstractband AGENS Methoden-Workshop. http:\/\/www.ismg.ovgu.de\/AGENS2019\/Abstracts\/_\/AGENS_WS_2019_Abstractband.pdf. Zugegriffen: 27. Mai 2019"},{"key":"3068_CR26","unstructured":"Deckenbach B, Nolting H\u2011D, Tisch T, Zich K (2018) Versorgungsreport Diabetes mellitus. https:\/\/www.dak.de\/dak\/download\/dak-versorgungsreport-2018-2019334.pdf. Zugegriffen: 15. Mai 2019"},{"key":"3068_CR27","unstructured":"Institut GmbH IGES (2012) Bewertung der Kodierqualit\u00e4t von vertrags\u00e4rztlichen Diagnosen. https:\/\/www.gkv-spitzenverband.de\/media\/dokumente\/krankenversicherung_1\/aerztliche_versorgung\/verguetung_und_leistungen\/klassifikationsverfahren\/9_Endbericht_Kodierqualitaet_Hauptstudie_2012_12-19.pdf. Zugegriffen: 14. Mai 2019"},{"key":"3068_CR28","unstructured":"Dr\u00f6sler S, Neukirch B, Ulrich V, Wille E (2016) Weiterentwicklungsbedarf des Versichertenklassifikationsverfahrens im Anwendungskontext der vertrags\u00e4rztlichen Versorgung. https:\/\/www.zi.de\/fileadmin\/images\/content\/Gutachten\/KBV-Zi-Gutachten_Klassifikationsverfahren_2016-10-31.pdf. Zugegriffen: 14. Mai 2019"},{"key":"3068_CR29","unstructured":"Dr\u00f6sler S, Neukirch B (2014) Evaluation der Kodierqualit\u00e4t von vertrags\u00e4rztlichen Diagnosen. http:\/\/www.kbv.de\/media\/sp\/2014_11_18_Gutachten_Kodierqualitaet.pdf. Zugegriffen: 14. Mai 2019"},{"key":"3068_CR30","unstructured":"Informationssystem der Gesundheitsberichterstattung des Bundes (IS-GBE) Renten wegen verminderter Erwerbsf\u00e4higkeit in der Gesetzlichen Rentenversicherung. www.gbe-bund.de. Zugegriffen: 6. Juni 2019"},{"key":"3068_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/pedi.12621","volume":"19","author":"B Bohn","year":"2018","unstructured":"Bohn\u00a0B, Schwandt\u00a0A, Ihle\u00a0P et\u00a0al (2018) Hospital admission in children and adolescents with or without type 1 diabetes from Germany: an analysis of statutory health insurance data on 12 million subjects. Pediatr Diabetes 19:721\u2013726","journal-title":"Pediatr Diabetes"},{"key":"3068_CR32","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (2019) Bestimmung der GKV-Zielpopulation f\u00fcr die Indikation Diabetes mellitus Typ 2 mittels GKV-Routinedaten. www.iqwig.de. Zugegriffen: 6. Juni 2019"},{"key":"3068_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1210\/jc.2014-3421","volume":"100","author":"JP Domecq","year":"2015","unstructured":"Domecq\u00a0JP, Prutsky\u00a0G, Leppin\u00a0A et al (2015) Clinical review: Drugs commonly associated with weight change: a\u00a0systematic review and meta-analysis. J\u00a0Clin Endocrinol Metab 100:363\u2013370","journal-title":"J Clin Endocrinol Metab"},{"key":"3068_CR34","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00125-017-4343-y","volume":"60","author":"SM Marshall","year":"2017","unstructured":"Marshall\u00a0SM (2017) 60 years of metformin use: a\u00a0glance at the past and a\u00a0look to the future. Diabetologia 60:1561\u20131565","journal-title":"Diabetologia"},{"key":"3068_CR35","unstructured":"Weinhold I, Claus F, Kossak N, H\u00e4ckl D (2017) Gutachten zum Forschungsprojekt \u201eKodierwettbewerb\u201c \u2013 WIG2 Wissenschaftliches Institut f\u00fcr Gesundheits\u00f6konomie und Gesundheitssystemforschung. https:\/\/www.wig2.de\/fileadmin\/content_uploads\/PDF_Dateien\/TK-Gutachten-zur-Einflussnahme-von-Krankenkassen.pdf. Zugegriffen: 20. Mai 2019"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-03068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-019-03068-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-03068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T01:00:53Z","timestamp":1606784453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-019-03068-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3068"],"URL":"https:\/\/doi.org\/10.1007\/s00103-019-03068-9","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"2 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Schmidt, L.\u00a0Reitzle, J.\u00a0Dre\u00df, A.\u00a0Rommel, T.\u00a0Ziese und C.\u00a0Heidemann geben an, dass kein Interessenkonflikt besteht. Das Projekt \u201eAufbau einer Nationalen Diabetes-Surveillance am Robert Koch-Institut\u201c wird unter dem F\u00f6rderkennzeichen GE 20150323 vom Bundesministerium f\u00fcr Gesundheit finanziert. Geldgeber und Dateneigner haben keinen Einfluss auf Planung, Durchf\u00fchrung, Analyse und Interpretation der im Rahmen der Diabetes-Surveillance erarbeiteten Studie genommen. Die Datenaufbereitungsstelle ist \u00fcber eine Co-Autorenschaft an der Studie beteiligt.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag verwendet keine personenbezogenen Daten, sondern die Ergebnisse wurden auf Basis aggregierter Daten ermittelt.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}